Skip to main content
Clinical Trials/NCT04449211
NCT04449211RecruitingPhase 1

The Effectiveness in the Treatment of Long Bone Defect in Adults Using 3D-printed Titanium Alloy Implant

Cho Ray Hospital1 site in 1 country10 target enrollmentStarted: October 6, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 1
Status
Recruiting
Enrollment
10
Locations
1
Primary Endpoint
Functional outcome of the upper limb

Study Overview

Brief Summary

To evaluate the effectiveness of 3D-printed titanium alloy implants in the treatment of long bone defect in adults

Detailed Description

The participant with long bone defect or bone tumor of the extremity is referred to the Radiology Department to have a full CT-scan of both limbs to facilitate the later reconstruction. With the contralateral limb CT-scan data, the implant is designed with appropriate geometry and structures through online meetings with the scientists of CSIRO, Australia. Through this discussion, the supporting guides for the precise osteotomy will also be designed and would be 3D-printed later by 3 Dimensional Tech Vision Limited Company (Vietnam) with Poly Lactic Acid material. The 3D-printed metal parts will be manufactured using Titanium - 6 Aluminum - 4 Vanadium ELI (Extra Low Interstitial) material with Electron Beam Melting technology in CSIRO (Australia). Subsequently, the 3D-printed part will undergo mechanical tests using the Instron 5500R system (Australia) to validate its required mechanical properties. If this metal part cannot fulfill the mechanical requirements, the problematic geometry will be revised and re-designed. Another prototype will be 3D-printed with the same protocol and be tested until it qualified for the mechanical requirement. When the 3D-printed model passes the mechanical test, another 3D-printed metal part with a similar design will be manufactured before transferring to 3-Dimensional Tech Vision Limited Company (Vietnam) for post-processing, surface finishing, sterilising, packaging, labeling. Eventually, the implant will be sent to Cho Ray hospital. The amount of intraoperative blood loss and operative time will be recorded.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Adult participants with health insurance regardless of sex having bone defect greater than 5cm due to trauma or tumour resection agree to participate the research

Exclusion Criteria

  • •Participants with contraindication to surgery
  • •Participants do not agree to undergo surgery
  • •Participants with local infection or soft tissue defect

Arms & Interventions

Participants with massive bone defect

Experimental

Adult participants with health insurance regardless of sex having bone defect greater than 5cm due to trauma or tumour resection agree to participate the research.

The customised 3D-Printed implant is manufactured and undergoes post-processing treatment before being ready for implantation surgery.

Intervention: Implantation (Device)

Outcomes

Primary Outcomes

Functional outcome of the upper limb

Time Frame: 1 to 12 months

For the participant with bone defect of the upper limb, the Disabilities of the Arm, Shoulder, and Hand (DASH) score will be used to evaluate for the limb functional outcome. The scale is ranging from 0 (no disability) to 100 (most severe disability).

Functional outcome of the lower limb

Time Frame: 1 to 12 months

For the participant with bone defect of the lower limb, the Karlstrom \& Olerud score will be used to evaluate for the limb functional outcome. The scale is graded as: bad, fair, good, excellent functional outcome.

Radiological imaging

Time Frame: Post-operative day 1 to 12 months

the bone healing process is evaluated by the change in dual energy CT-scan result

Secondary Outcomes

  • Complications(through study completion, an average of 1 year.)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Hung Do Phuoc, MD, PhD

Associate Professor

Cho Ray Hospital

Study Sites (1)

Loading locations...

Similar Trials